Apoptotic index and apoptosis influencing proteins bcl-2, mcl-1, bax and caspases 3, 6 and 8 in pancreatic carcinoma

Histopathology

Volumn 33, Issue 5, 1998, Pages 432-439

  Virkajarvi N ^a   Paakko P ^a   Soini, Y ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Apoptosis; Bax; Bcl 2; Carcinoma; Caspases; Pancreas

Indexed keywords

CASPASE 3; CASPASE 6; CASPASE 8; CYSTEINE PROTEINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MCL 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY;

ADENOCARCINOMA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 6; CASPASE 8; CASPASE 9; CASPASES; ENZYME PRECURSORS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0031770074     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1998.00553.x     Document Type: Article

References (31)

1. Reed JC. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 1944; 124; 1-6.
2. Hockenbery DM. Bcl-2 in cancer, development and apoptosis. J. Cell Sci. 1994; 18; 51-55.
3. White E. Life, death, and the pursuit of apoptosis. A review. Gene Dev. 1996; 19; 1-15.
4. Yang E, Korsmeyer SK. Molecular thanatopsis: A discourse on the bcl-2 family and cell death. Blood 1996; 88; 386-401.
5. Kroemer G. The proto-oncogene bcl-2 and its role in regulating apoptosis. Nature Med. 1997; 3; 614-620.
6. Huang DCS, O'Reilly LA, Strasser A, Cory S. The anti-apoptosis function of bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 1997; 16; 4628-4638.
7. Minn AJ, Velez P, Schendel SL et al. Bcl-xL forms an ion channel in synthetic lipid membranes. Nature 1997; 385; 353-357.
8. Yang J, Liu X, Bhalla K et al. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275; 1129-1132.
9. Kluck RM, Bossy-Wetzel E, Green DR, Nwemeyer DD. The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science 1997; 275; 1132-1136.
10. Manon S, Chaudhuri B, Guerin M. Release of cytochrome c and decrease of cytochrome c oxidase in bax-expressing yeast cells. and prevention of these effects by coexpression of bcl-xL. FEBS Lett. 1997; 415; 29-32.
11. Barge RMY, Willemze R, Vandenabeele P, Fiers W, Beyaert R. Differential involvement of caspases in apoptosis of myeloid leukemic cells induced by chemotherapy versus growth factor withdrawal. FEBS Lett. 1997; 409; 207-210.
12. Harvey NL, Butt AJ, Kumar S. Functional activation of Nedd2/ ICH-1 (Caspase-2) is an early process in apoptosis. J. Biol. Chem. 1997; 272; 13134-13139.
13. Thornberry NA, Peterson EP, Zhao JJ, Howard AD, Griffin PR, Chapman KT. Inactivation of interleukin-1β converting enzyme by peptide (acyloxy) methyl ketones. Biochemistry 1994; 33; 3934-3940.
14. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J. 1996; 10; 587-597.
15. Rao L, Perez D, White E. Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell Biol. 1996; 135; 1441-1455.
16. Brancolini C, Lazarevic D, Rodriguez J, Schneider C. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolylic cleavage of β-catenin. J. Cell Biol. 1997; 139; 759-771.
17. Caulin C, Salvesen GS, Oshima RG. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell Biol. 1997; 138; 1379-1394.
18. Chen L, Marechal V, Moreau J, Levine AJ, Chen J. Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. J. Biol. Chem. 1997; 272; 22966-22973.
19. Tan X, Martin SJ, Green DR, Wang JYJ. Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J. Biol. Chem. 1997; 272; 9613-9616.
20. Nagata S. Apoptosis by death factor. Cell 1997; 88; 355-365.
21. Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD-Homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85; 817-827.
22. Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH. Histological typing of tumours of the exocrine pancreas. World Health Organization. International Histological Classification of Tumours. 2nd edn. Berlin: Springer, 1996.
23. Klöppel G, Ligenthal G, von Bulow M, Kern HF. Histological and line structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinicohistopathological correlation in a series of 75 cases. Histopathology 1985; 9; 841-856.
24. Törmänen U, Eerola A-K, Rainio P et al. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res. 1995; 55; 5595-5602.
25. Soini Y, Virkajärvi N, Lehto V-P, Pääkkö P. Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br. J. Cancer 1996; 73; 1025-1030.
26. Sinicrope FA, Evans DB, Leach SD et al. Bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome. Clin. Cancer Res. 1996; 2; 2015-2022.
27. Mustonen M, Raunio H, Pääkkö P, Soini Y. The extent of apoptosis is inversely associated with bcl-2 expression in premalignant and malignant breast lesions. Histopathology 1997; 31; 347-354.
28. Saegusa M, Kamata Y, Isono M, Okayasu I. Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivily in endometrial carcinomas. J. Pathol. 1996; 180; 275-282.
29. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med. 1997; 3; 917-921.
30. Wada M, Doi R, Hosotani R et al. Expression of bcl-2 and PCNA in duct cells after pancreatic duct ligation in rats. Pancreas 1997; 15; 176-182.
31. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am. J. Pathol. 1994; 145; 1323-1336.